In T1DM, β-cell destruction leads to the disruption of the insulin signalling pathway, whereas with T2DM, the key insulin-sensitive cells become resistant to the effects of insulin, therefore impairing the signalling pathway’s ability to effectively maintain glucose homeostasis [5,6]. The gene discussed is INS; the disease is type 1 diabetes mellitus.